BackBioXcel Therapeutics Overview

BioXcel Therapeutics Profit Margin

Profitability ratio analysis for BTAI.

Quarterly Profit Margin

-6160.68%
↓ 42.68% YoY

As of Mar 2026

Annual Profit Margin (TTM)

-11078.53%
↓ 412.14% YoY

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin